Acasti Pharma Inc. ACST
We take great care to ensure that the data presented and summarized in this overview for Acasti Pharma Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ACST
Top Purchases
Top Sells
About ACST
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Insider Transactions at ACST
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2023
|
Vimal Kavuru |
BUY
Open market or private purchase
|
Indirect |
676,371
+36.28%
|
$676,371
$1.85 P/Share
|
|
Aug 31
2023
|
Donald Olds Director |
BUY
Open market or private purchase
|
Direct |
381
+50.0%
|
$762
$2.05 P/Share
|
Last 12 Months Summary
Buy / Acquisition
677K
Shares
From
2
Insiders
| Open market or private purchase | 677K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders